Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Show other versions (1)

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium
Formato:	Journal article
Publicado em:	Company of Biologists 2017

Registos relacionados

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Por: Bowerman, M, et al.
Publicado em: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Por: Melissa Bowerman, et al.
Publicado em: (2017-08-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Por: Winkelsas, AM, et al.
Publicado em: (2021)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Por: Audrey M. Winkelsas, et al.
Publicado em: (2021-03-01)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
Por: Wishart, T, et al.
Publicado em: (2010)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
Por: Wood, M, et al.
Publicado em: (2017)

SMN post-translational modifications in spinal muscular atrophy
Por: Giulietta M. Riboldi, et al.
Publicado em: (2023-02-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
Por: Yuri Yépez, et al.
Publicado em: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Por: Darija Šoltić, et al.
Publicado em: (2020-03-01)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
Por: Sleigh, J, et al.
Publicado em: (2011)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
Por: Li-Kai Tsai
Publicado em: (2012-01-01)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Publicado em: (2020-04-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Por: Niko Hensel, et al.
Publicado em: (2020-02-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
Por: Tejal Aslesh, et al.
Publicado em: (2022-01-01)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
Por: Valeria Valsecchi, et al.
Publicado em: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
Por: Chen-Hung Ting, et al.
Publicado em: (2012-01-01)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
Por: Paola Bernabò, et al.
Publicado em: (2017-10-01)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
Por: Ilaria Signoria, et al.
Publicado em: (2024-12-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
Por: A. I. Vlasenko, et al.
Publicado em: (2024-12-01)

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN
Por: Rademacher, S, et al.
Publicado em: (2020)

Spinal muscular atrophy.
Por: Talbot, K, et al.
Publicado em: (2001)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
Por: Claribel D Wee, et al.
Publicado em: (2014-01-01)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
Por: James N. Sleigh, et al.
Publicado em: (2011-07-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
Por: Fabián Lombillo-Alfonso, et al.
Publicado em: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
Por: Fabián Lombillo, et al.
Publicado em: (2019-05-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
Por: Ines Tapken, et al.
Publicado em: (2024-05-01)

Development and Translation of Therapies for Spinal Muscular Atrophy
Por: Hannah K. Shorrock, et al.
Publicado em: (2016-07-01)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
Por: Murray, L, et al.
Publicado em: (2010)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Por: Winkelsas, AM
Publicado em: (2020)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
Por: Matthew E.R. Butchbach, et al.
Publicado em: (2007-08-01)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
Por: Sebastian Rademacher, et al.
Publicado em: (2020-11-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
Por: W. Arnold, et al.
Publicado em: (2016-03-01)

Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations
Por: Sharon J. Brown, et al.
Publicado em: (2025-07-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
Por: Niba, Emma Tabe Eko, et al.
Publicado em: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
Por: Niba, Emma Tabe Eko, et al.
Publicado em: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
Por: Poh San Lai, et al.
Publicado em: (2024-01-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
Por: Anderton Ryan, et al.
Publicado em: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Por: Amparo Garcia-Lopez, et al.
Publicado em: (2018-05-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
Por: Owen, N, et al.
Publicado em: (2002)

Chapter 16 Spinal Muscular Atrophy
Por: Talbot, K, et al.
Publicado em: (2003)